The World Market for Hematology
Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by Kalorama Analyst Emil Salazar, defines the market worldwide for analyzers, point of care tests, stains and slides and imaging systems used in hematology testing.
Hematology test results such as abnormal CBC results often prompt differentials and other non-hematological confirmatory testing that may diagnose diseases such as autoimmune disorders, blood cancers, long-term infections, acute infectious diseases, liver and spleen diseases, bone marrow disorders and malignancies.
Extensive Hematology Market Data
As part of this report’s exhaustive coverage, the following data is provided.
- CBC Count Test Volumes For 16 Countries and 6 Regions
- Hematology Analyzer Market by Analyzer Client Segment Markets – POL/Small Clinical Lab, Medium and Large Clinical Labs, Commercial Labs
Hematology Analyzer Revenue Breakout Instrument, Consumables – Lease/Rental/Contract, Consumables – Base (Analyzers), Service
Analyzer Market Share
Slidemaker/Stainer Market Share
Digital Imaging Market Share
Point-of-Care Hemoglobin Market Share
Important Analyst Conclusions About the Market
Global Coverage of the Hematology Market
This report provides coverage of hematology markets worldwide to assist customers conducting global business planning. Both market sizing and company market share is provided with regional breakout.
US and Canada Hematology Market (Canada, U.S.)
Europe Hematology Market
Brazil, Mexico and Other Latin America Market
China, Japan, Australia and Other Asian-Pacific Hematology Markets
Rest of World Market
North American Hematology Market Share
European Hematology Market Share
Asia-Pacific Hematology Market Share
Key Analyzer, POC, Slide and Imaging Manufacturers
In clinical terminology and medicine, hematology is the study of peripheral blood cells and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia, autoimmune disorders, and other blood disorders. Hematology can also be used to monitor patient health and alert medical professionals to diseases requiring diagnosis through additional testing or changes to ongoing treatment. Clinical hematology leverages various IVD technologies including blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis or coagulation testing, histology, and cytology.
This report defines the hematology market and industry according to the conventions of IVD manufacturers, with core hematology testing contained in the above list. Other IVD testing forms utilized in clinical hematology – histology, cytology, erythrocyte sedimentation rate (ESR), variant hemoglobin screening, flow cytometry – are discrete product areas apart from core laboratory hematology, and represented largely by different companies.
Hematology Market Company Profiles
The report provides detailed profiles of the following companies:
Siemens Healthcare Diagnostics